There are 2934 resources available
2016 - High Immunoscore is associated with good response to neo-adjuvant chemotherapy and prolonged survival in advanced Head and Neck cancer patients.
Presenter: Haitham Mirghani
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
2603 - Analysis of Efficacy Outcomes Based on Programmed Death Ligand 1 (PD-L1) Scoring Techniques in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) From KEYNOTE-040
Presenter: Ezra Cohen
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4782 - A window of opportunity trial of preoperative nivolumab with or without tadalafil in squamous cell carcinoma of the head and neck (SCCHN): safety, clinical, and correlative outcomes
Presenter: Adam Luginbuhl
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
2557 - Pembrolizumab and radiotherapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) with contraindication to cisplatin therapy
Presenter: Siddharth Sheth
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4934 - Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): safety phase of randomized trial GORTEC 2017-01 (REACH)
Presenter: Yungan Tao
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
4541 - Inducible T cell Costimulatory (ICOS) Receptor Agonist, GSK3359609 (GSK609) alone and in combination with Pembrolizumab (pembro): preliminary results from INDUCE-1 expansion cohorts (EC) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Presenter: Danny Rischin
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
3463 - Buparlisib (BKM120) in refractory head and neck squamous cell carcinoma harbouring or not a PI3KCA mutation: a phase II multicenter trial
Presenter: Jérome Fayette
Session: Poster Discussion – Head and neck cancer
Resources:
Abstract
Genetic counselling and screening
Presenter: Ashley Grossman
Session: A family with MEN1 syndrome
Resources:
Slides
Webcast
1774 - Characterization of a novel BBB-permeable mutant IDH1 inhibitor, DS-1001b.
Presenter: Hironori Matsunaga
Session: Poster Discussion – CNS tumours
Resources:
Abstract
3522 - Precision medicine for patients with primary brain tumors: Molecular Screening for Cancer Treatment Optimization (MOSCATO) prospective trial
Presenter: Wafa Boulfoul
Session: Poster Discussion – CNS tumours
Resources:
Abstract